Humalog Kwikpen Solution For Injection 100U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Humalog KwikPen: Solution for injection (100U)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file default-drug-image.png
Humalog 100unit/ml KwikPen Inj

What is this Medicine?

INSULIN LISPRO (IN su lin LYE sproe) is a human-made form of insulin. This drug lowers the amount of sugar in your blood. This medicine is a rapid-acting insulin that starts working faster than regular insulin. It will not work as long as regular insulin.

CVS Pharmacy Patient Statistics for Humalog KwikPen: Solution for injection(100U)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Humalog KwikPen 100unit/ml Pre-Filled Pen Solution for Injection

NDC: 000028799
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Sometimes used for but not FDA approved for the following conditions:
Diabetic Ketoacidosis

Storage Information
Opened container can be stored for up to 28 days at temperatures below 86 degrees F
Protect from light
Do not use if product has been frozen
Store unopened containers in refrigerator (36 to 46 degrees F)
Protect from extreme heat
Unrefrigerated product must be used within 28 days or be discarded
Do not freeze
Humalog KwikPen 100unit/ml Pre-Filled Pen Solution for Injection
Close All Sections Show

Reported Side Effects for Humalog KwikPen 100unit/ml Pre-Filled Pen Solution for Injection

Close Show
Weakness Incidence:
<7.4%*
Severity: MILD
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Severe Low Blood Sugar Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<6.2%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.0%*
Severity: MILD
Onset: RAPID
Injection Site Reaction Incidence:
1.0-21.0%*
Severity: MILD
Onset: RAPID
Infusion-related Reactions Incidence:
2.6%*
Severity: MODERATE
Onset: RAPID
Fever Incidence:
6.2%*
Severity: MILD
Onset: EARLY
Menstrual Cramps Incidence:
6.2%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
6.6-33.3%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
7.4%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
8.1-24.7%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
8.6%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
>10.0%*
Severity: MODERATE
Onset: EARLY
Infection Incidence:
10.1-13.6%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
11.6-29.6%*
Severity: MILD
Onset: EARLY
Cough Incidence:
17.3%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Humalog KwikPen

Close Show

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.